112 related articles for article (PubMed ID: 10470108)
1. Metabolite composition in breast tumors examined by proton nuclear magnetic resonance spectroscopy.
Gribbestad IS; Sitter B; Lundgren S; Krane J; Axelson D
Anticancer Res; 1999; 19(3A):1737-46. PubMed ID: 10470108
[TBL] [Abstract][Full Text] [Related]
2. In vitro proton NMR spectroscopy of extracts from human breast tumours and non-involved breast tissue.
Gribbestad IS; Fjösne HE; Haugen OA; Nilsen G; Krane J; Petersen SB; Kvinnsland S
Anticancer Res; 1993; 13(6A):1973-80. PubMed ID: 8297103
[TBL] [Abstract][Full Text] [Related]
3. Comparison of HR MAS MR spectroscopic profiles of breast cancer tissue with clinical parameters.
Sitter B; Lundgren S; Bathen TF; Halgunset J; Fjosne HE; Gribbestad IS
NMR Biomed; 2006 Feb; 19(1):30-40. PubMed ID: 16229059
[TBL] [Abstract][Full Text] [Related]
4. Metabonomic studies of human hepatocellular carcinoma using high-resolution magic-angle spinning 1H NMR spectroscopy in conjunction with multivariate data analysis.
Yang Y; Li C; Nie X; Feng X; Chen W; Yue Y; Tang H; Deng F
J Proteome Res; 2007 Jul; 6(7):2605-14. PubMed ID: 17564425
[TBL] [Abstract][Full Text] [Related]
5. Classification of in vivo 1H MR spectra from breast tissue using artificial neural networks.
Bakken IJ; Axelson D; Kvistad KA; Gribbestad IS
Anticancer Res; 2001; 21(2B):1481-5. PubMed ID: 11396236
[TBL] [Abstract][Full Text] [Related]
6. MR-determined metabolic phenotype of breast cancer in prediction of lymphatic spread, grade, and hormone status.
Bathen TF; Jensen LR; Sitter B; Fjösne HE; Halgunset J; Axelson DE; Gribbestad IS; Lundgren S
Breast Cancer Res Treat; 2007 Aug; 104(2):181-9. PubMed ID: 17061040
[TBL] [Abstract][Full Text] [Related]
7. Preliminary study of 3T 1H MR spectroscopy in bone and soft tissue tumors.
Qi ZH; Li CF; Li ZF; Zhang K; Wang Q; Yu DX
Chin Med J (Engl); 2009 Jan; 122(1):39-43. PubMed ID: 19187615
[TBL] [Abstract][Full Text] [Related]
8. Ex vivo proton MR spectroscopy (1H-MRS) for evaluation of human gastric carcinoma.
Mun CW; Cho JY; Shin WJ; Choi KS; Eun CK; Cha SS; Lee J; Yang YI; Nam SH; Kim J; Lee SY
Magn Reson Imaging; 2004 Jul; 22(6):861-70. PubMed ID: 15234456
[TBL] [Abstract][Full Text] [Related]
9. Quantification of metabolites in breast cancer patients with different clinical prognosis using HR MAS MR spectroscopy.
Sitter B; Bathen TF; Singstad TE; Fjøsne HE; Lundgren S; Halgunset J; Gribbestad IS
NMR Biomed; 2010 May; 23(4):424-31. PubMed ID: 20101607
[TBL] [Abstract][Full Text] [Related]
10. Visualizing metabolic changes in breast-cancer tissue using 1H-NMR spectroscopy and self-organizing maps.
Beckonert O; Monnerjahn J; Bonk U; Leibfritz D
NMR Biomed; 2003 Feb; 16(1):1-11. PubMed ID: 12577292
[TBL] [Abstract][Full Text] [Related]
11. High-resolution magic angle spinning MRS of breast cancer tissue.
Sitter B; Sonnewald U; Spraul M; Fjösne HE; Gribbestad IS
NMR Biomed; 2002 Aug; 15(5):327-37. PubMed ID: 12203224
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of total choline from in-vivo volume localized proton MR spectroscopy and its response to neoadjuvant chemotherapy in locally advanced breast cancer.
Jagannathan NR; Kumar M; Seenu V; Coshic O; Dwivedi SN; Julka PK; Srivastava A; Rath GK
Br J Cancer; 2001 Apr; 84(8):1016-22. PubMed ID: 11308247
[TBL] [Abstract][Full Text] [Related]
13. Applications of neural network analyses to in vivo 1H magnetic resonance spectroscopy of Parkinson disease patients.
Axelson D; Bakken IJ; Susann Gribbestad I; Ehrnholm B; Nilsen G; Aasly J
J Magn Reson Imaging; 2002 Jul; 16(1):13-20. PubMed ID: 12112498
[TBL] [Abstract][Full Text] [Related]
14. In vivo proton magnetic resonance spectroscopy of breast lesions: an update.
Tse GM; Yeung DK; King AD; Cheung HS; Yang WT
Breast Cancer Res Treat; 2007 Sep; 104(3):249-55. PubMed ID: 17051424
[TBL] [Abstract][Full Text] [Related]
15. 1H magnetic resonance spectroscopy of invasive cervical cancer: an in vivo study with ex vivo corroboration.
Mahon MM; Williams AD; Soutter WP; Cox IJ; McIndoe GA; Coutts GA; Dina R; deSouza NM
NMR Biomed; 2004 Feb; 17(1):1-9. PubMed ID: 15011245
[TBL] [Abstract][Full Text] [Related]
16. [In vitro NMR spectroscopy of healthy, pathologically changed and carcinomatous breast tissue samples correlated with histological findings].
Speckter H; Blümich B; Just M; Trömel U; Mitze M; Thelen M
Rofo; 1994 Aug; 161(2):147-53. PubMed ID: 8054548
[TBL] [Abstract][Full Text] [Related]
17. Longitudinally monitoring chemotherapy effect of malignant musculoskeletal tumors with in vivo proton magnetic resonance spectroscopy: an initial experience.
Hsieh TJ; Li CW; Chuang HY; Liu GC; Wang CK
J Comput Assist Tomogr; 2008; 32(6):987-94. PubMed ID: 19204465
[TBL] [Abstract][Full Text] [Related]
18. 31P magnetic resonance spectroscopic profiles of neoplastic human breast tissues.
Merchant TE; Gierke LW; Meneses P; Glonek T
Cancer Res; 1988 Sep; 48(18):5112-8. PubMed ID: 3409237
[TBL] [Abstract][Full Text] [Related]
19. Investigation of breast cancer using two-dimensional MRS.
Thomas MA; Lipnick S; Velan SS; Liu X; Banakar S; Binesh N; Ramadan S; Ambrosio A; Raylman RR; Sayre J; DeBruhl N; Bassett L
NMR Biomed; 2009 Jan; 22(1):77-91. PubMed ID: 19086016
[TBL] [Abstract][Full Text] [Related]
20. In vivo proton magnetic resonance spectroscopy of large focal hepatic lesions and metabolite change of hepatocellular carcinoma before and after transcatheter arterial chemoembolization using 3.0-T MR scanner.
Kuo YT; Li CW; Chen CY; Jao J; Wu DK; Liu GC
J Magn Reson Imaging; 2004 May; 19(5):598-604. PubMed ID: 15112309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
